These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 14984635)
1. Thrombotic thrombocytopenic purpura associated with abacavir in a patient with HIV infection. Olszewski AJ; Shapiro JM J Intensive Care Med; 2003; 18(3):156-9. PubMed ID: 14984635 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric reaction induced by abacavir in a pediatric human immunodeficiency virus-infected patient. Soler Palacin P; Aramburo A; Moraga FA; Cabañas MJ; Figueras C Pediatr Infect Dis J; 2006 Apr; 25(4):382. PubMed ID: 16568000 [No Abstract] [Full Text] [Related]
11. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients. Bellagamba R; Tommasi C; De Marco M; Narciso P J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915 [No Abstract] [Full Text] [Related]
12. The importance of CD4 count, viral load and highly active antiretroviral therapy in HIV-associated thrombotic thrombocytopenic purpura (TTP). Hill QA; Minton J Sex Transm Infect; 2012 Feb; 88(1):38-9. PubMed ID: 22045846 [TBL] [Abstract][Full Text] [Related]
18. Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. Martínez E; Larrousse M; Podzamczer D; Pérez I; Gutiérrez F; Loncá M; Barragán P; Deulofeu R; Casamitjana R; Mallolas J; Pich J; Gatell JM; AIDS; 2010 Jan; 24(3):F1-9. PubMed ID: 20009917 [TBL] [Abstract][Full Text] [Related]
19. Sweet's syndrome following abacavir therapy. Del Giudice P; Vandenbos F; Perrin C; Bernard E; Marq L; Dellamonica P J Am Acad Dermatol; 2004 Sep; 51(3):474-5. PubMed ID: 15337997 [No Abstract] [Full Text] [Related]
20. 1592 (abacavir): do not rechallenge after hypersensitivity reaction. James JS AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]